GlycoNAVI-Proteins is dataset of glycan and protein information. This is the content of GlycoNAVI.
Source | Last Updated |
---|---|
GlycoNAVI Proteins | December 18, 2024 |
PDB ID | UniProt ID | Title ▲ | Descriptor |
---|---|---|---|
6W41 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022 | |
6W41 | 6W41 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with human antibody CR3022 | |
7S5R | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16 | |
7S5R | 7S5R | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibodies CV07-287 and COVA1-16 | |
8GB7 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 20A7 | |
8GB7 | 8GB7 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 20A7 | |
8GB6 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 21B6 | |
8GB6 | 8GB6 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 21B6 | |
8GB5 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9 | |
8GB5 | 8GB5 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 25F9 | |
7MF1 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1 | |
7MF1 | 7MF1 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody 47D1 | |
7U2D | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADG20 | |
7U2D | 7U2D | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADG20 | |
7U2E | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADI-55688 | |
7U2E | 7U2E | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody ADI-55688 | |
6XC2 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1 | |
6XC2 | 6XC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.1 | |
6XC4 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3 | |
6XC4 | 6XC4 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC12.3 | |
8SDF | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4 | |
8SDF | 8SDF | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.4 | |
8SDG | 8SDG | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.43 | |
8SDG | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.43 | |
8SDH | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.56 | |
8SDH | 8SDH | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CC25.56 | |
7JMO | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04 | |
7JMO | 7JMO | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-04 | |
9B82 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-15 | |
9B82 | 9B82 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-15 | |
7JMP | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39 | |
7JMP | 7JMP | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody COVA2-39 | |
6XKQ | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250 | |
6XKQ | 6XKQ | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-250 | |
6XKP | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270 | |
6XKP | 6XKP | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody CV07-270 | |
7TP4 | 7TP4 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.22 | |
7TP4 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody K398.22 | |
8FI9 | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody WRAIR-5001 | |
8FI9 | 8FI9 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing antibody WRAIR-5001 | |
8EOO | 8EOO | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibodies WRAIR-2063 and WRAIR-2151 | |
8EOO | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibodies WRAIR-2063 and WRAIR-2151 | |
7N4I | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057. | |
7N4I | 7N4I | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2057. | |
7N4M | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2151. | |
7N4M | 7N4M | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2151. | |
7N4J | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173. | |
7N4J | 7N4J | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing human antibody WRAIR-2173. | |
7FBJ | P0DTC2 | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6 | |
7FBJ | 7FBJ | Crystal structure of SARS-CoV-2 receptor binding domain in complex with neutralizing nanobody 17F6 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
GlyCosmos Portal v4.1.0
Last updated: December 9, 2024